AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Renerve Ltd

0.068

-0.007-9.33%

Volume:28.33K

Turnover:2K

Market Cap:11.72M

PE:-2.13

High:0.073

Open:0.073

Low:0.068

Close:0.075

52wk High:0.220

52wk Low:0.068

Shares:172.30M

Float Shares:65.22M

Volume Ratio:0.39

T/O Rate:0.04%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.032

EPS(LYR):-0.030

ROE:-74.94%

ROA:-47.64%

PB:2.20

PE(LYR):-2.24

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

ReNerve Says Nervalign Nerve Cuff Receives CDSCO Marketing Approval in India

Renerve - Nervalign Nerve Cuff Receives Cdsco Marketing Approval in India

THOMSON REUTERS

Renerve - Receives Marketing Approval for Nervalign Nerve Cuff in Philippines

THOMSON REUTERS

Australia's Renerve Rises on Securing up to A$5 Million Funding Facility

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au.tigermarketb.com/stock/RNV.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"RNV.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"RNV.AU\",,,,,undefined,":{"symbol":"RNV.AU","market":"AU","secType":"STK","nameCN":"Renerve Ltd","latestPrice":0.068,"timestamp":1787802528383,"preClose":0.075,"halted":0,"volume":28325,"delay":0,"changeRate":-0.09333333333333324,"nameEN":"Renerve Ltd","floatShares":65224917,"shares":172300135,"eps":-0.031951,"marketStatus":"Trading","change":-0.007,"latestTime":"08-27 14:57:52 AEST","open":0.073,"high":0.073,"low":0.068,"amount":1946,"amplitude":0.066667,"askPrice":0.073,"askSize":7000,"bidPrice":0.071,"bidSize":30000,"shortable":3,"etf":0,"ttmEps":-0.031951,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1787810400000},"marketStatusCode":2,"adr":0,"listingDate":1732194000000,"exchange":"ASX","adjPreClose":0.075,"openAndCloseTimeList":[[1787788800000,1787810400000]],"volumeRatio":0.394781,"lotSize":0,"tradeCurrency":"AUD","auctionPricing":{"symbol":"RNV.AU","preClose":0.075,"auctionPrice":0.073,"auctionVolume":4000,"auctionTime":1787778025399,"referenceTime":1787135404091,"auction":1,"marketStatus":"盘前竞价","timestamp":1787778025399}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"RNV.AU\",,,,,undefined,":{"symbol":"RNV.AU","floatShares":65224917,"roa":"-47.64%","roe":"-74.94%","lyrEps":-0.030298,"volumeRatio":0.394781,"shares":172300135,"dividePrice":0,"high":0.073,"amplitude":0.066667,"preClose":0.075,"low":0.068,"week52Low":0.068,"pbRate":"2.20","psRate":"35.16","week52High":0.22,"institutionHeld":0,"latestPrice":0.068,"committee":0.621622,"eps":-0.031951,"divideRate":0,"volume":28325,"delay":0,"ttmEps":-0.031951,"open":0.073,"prevYearClose":0.1,"prevWeekClose":0.08,"prevMonthClose":0.085,"prevQuarterClose":0.077,"fiveDayClose":0.08,"twentyDayClose":0.08,"sixtyDayClose":0.076},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RNV.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RNV.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RNV.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658609975","title":"ReNerve Says Nervalign Nerve Cuff Receives CDSCO Marketing Approval in India","url":"https://stock-news.laohu8.com/highlight/detail?id=2658609975","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658609975?lang=en_us&edition=fundamental","pubTime":"2026-08-10 09:55","pubTimestamp":1786326909,"startTime":"0","endTime":"0","summary":"Aug 10 (Reuters) - ReNerve Ltd::*NERVALIGN NERVE CUFF RECEIVES CDSCO MARKETING APPROVAL IN INDIA*Further company coverage: RNV.AX* ((Reuters.Briefs@thomsonreuters.com;))((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))Source Date/Time = 10-AUG-202601:44:06 GMT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nRSDFg33d:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7126","RNV.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658606824","title":"Renerve - Nervalign Nerve Cuff Receives Cdsco Marketing Approval in India","url":"https://stock-news.laohu8.com/highlight/detail?id=2658606824","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658606824?lang=en_us&edition=fundamental","pubTime":"2026-08-10 08:45","pubTimestamp":1786322706,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nFWN44600R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RNV.AU","BK7126"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657557759","title":"Renerve - Receives Marketing Approval for Nervalign Nerve Cuff in Philippines","url":"https://stock-news.laohu8.com/highlight/detail?id=2657557759","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657557759?lang=en_us&edition=fundamental","pubTime":"2026-08-06 08:06","pubTimestamp":1785974791,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nFWN4421M0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7126","RNV.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650731943","title":"Australia's Renerve Rises on Securing up to A$5 Million Funding Facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2650731943","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650731943?lang=en_us&edition=fundamental","pubTime":"2026-07-09 12:33","pubTimestamp":1783571618,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's ReNerve rises on securing up to A$5 million funding facility** Shares of Australia's ReNerveRNV.AXgain 5.1% to A$0.083, their highest level since June 22** Shares on track for biggest intraday pct gain since June 16, if gains hold** Medical devices cosaysit has secured a convertible note funding facility from specialist financial and investment firm RiverFront** Adds the loan, which can later be converted into shares, is worth up to A$5 million ** Co plans to use funds to support commercialization of its products and expand US sales and distribution activities** Stock down 17% YTD","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260709:nL4N43B0AX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7126","RNV.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":4,"pageCount":1,"totalSize":15,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/RNV.AU\",params:#limit:6,delay:true,,,undefined,":[]}}